Mechanical circulatory devices in acute heart failure.

Area of Science:

• Cardiology
• Critical Care Medicine
• Medical Devices

Background:

• Temporary circulatory support (TCS) with short-term mechanical circulatory support (MCS) devices is increasingly used for refractory cardiogenic shock.
• Current evidence for TCS efficacy is limited, necessitating further research.

Purpose of the Study:

• To provide an overview of current TCS devices, indications, and management strategies.
• To discuss recent findings from case series and trials on TCS in cardiogenic shock.

Main Methods:

• Review of current literature on temporary mechanical circulatory support devices.
• Analysis of indications, management, and outcomes for devices like Impella and VA-ECMO.
• Discussion of emerging indications for TCS.

Main Results:

• Percutaneous MCS devices and VA-ECMO serve as a bridge to decision, allowing for various patient management pathways.
• VA-ECMO is often the first-line TCS due to rapid oxygenation improvement, cost-effectiveness, and suitability for biventricular failure.
• Emerging indications for TCS include sepsis-associated cardiomyopathy, massive pulmonary embolism, and arrhythmic storm.

Conclusions:

• TCS is a cornerstone in managing cardiogenic shock, with VA-ECMO as a leading first-line choice.
• Growing indications for TCS highlight its importance, but robust evidence is still developing.
• Randomized clinical trials are crucial to establish the optimal role of different MCS devices in cardiogenic shock treatment.